Education
About Us
Working with TipRanks
Follow Us
Biote Corp. (BTMD)
:BTMD
BTMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.17 - $8.44
Previous CloseN/A
Volume19.10K
Average Volume (3M)151.44K
Market Cap
$237.45M
Enterprise Value$267.61M
Total Cash (Recent Filing)$89.00M
Total Debt (Recent Filing)$114.87M
Price to Earnings (P/E)20.9
Beta1.31
Next Earnings
Mar 12, 2025EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding32,700,165
10 Day Avg. Volume149,807
30 Day Avg. Volume151,442
Standard Deviation0.17
R-Squared0.09
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)3.80
P/FCF Ratio4.40
Enterprise Value/Market Cap1.13
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.10
Enterprise Value/Ebitda15.92
Forecast
1Y Price Target
$11.00Price Target Upside151.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
biote News
PremiumCompany Announcements
Biote Announces CEO Transition Effective February 2025
PremiumCompany Announcements
Biote Corp. Reports Steady Growth in Q3 2024
---
Bulls Say, Bears Say
Bulls Say
Business StrategyBTMD's business enhancements and further verticalization are likely to put the company on a path of higher growth both on top and bottom lines.
Competitive PositionThe software enhancements can provide competitive advantages and solidify BTMD's competitive position.
Market DemandPatient and clinic demand remains robust and the dietary supplement business is rebounding.
Bears Say
Earnings GuidanceThe magnitude of the guide down for 4Q24 was relatively modest but indicates potential challenges ahead.
Financial PerformanceAdjusted EBITDA fell below expectations, despite delivering in-line sales.
Operational DisruptionsBTMD faced business disruptions from software enhancements and Hurricane Helene, which should also affect future performance.
---
Ownership Overview
67.37% Insiders
12.52% Mutual Funds
0.17% Other Institutional Investors
11.69% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BTMD FAQ
What was Biote Corp.’s price range in the past 12 months?
Biote Corp. lowest stock price was $4.17 and its highest was $8.44 in the past 12 months.
What is Biote Corp.’s market cap?
Biote Corp.’s market cap is $237.45M.
When is Biote Corp.’s upcoming earnings report date?
Biote Corp.’s upcoming earnings report date is Mar 12, 2025 which is in 8 days.
How were Biote Corp.’s earnings last quarter?
Biote Corp. released its earnings results on Nov 12, 2024. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.118 by $0.212.
Is Biote Corp. overvalued?
According to Wall Street analysts Biote Corp.’s price is currently Undervalued.
Does Biote Corp. pay dividends?
Biote Corp. does not currently pay dividends.
What is Biote Corp.’s EPS estimate?
Biote Corp.’s EPS estimate is 0.11.
How many shares outstanding does Biote Corp. have?
Biote Corp. has 32,700,165 shares outstanding.
What happened to Biote Corp.’s price movement after its last earnings report?
Biote Corp. reported an EPS of $0.33 in its last earnings report, beating expectations of $0.118. Following the earnings report the stock price went up 21.739%.
Which hedge fund is a major shareholder of Biote Corp.?
Currently, no hedge funds are holding shares in BTMD
---
biote Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.00 (151.72% Upside)
$11.00 (151.72% Upside)
Blogger Sentiment
Bullish
BTMD Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.39%
12-Months-Change
Fundamentals
Return on Equity
-7.92%
Trailing 12-Months
Asset Growth
-32.39%
Trailing 12-Months
Company Description
Biote Corp.
Haymaker Acquisition Corp III is a blank check company.
---
BTMD Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed sentiment with strong financial performance and growth in key areas like dietary supplements, but faced challenges due to software disruptions and natural disasters affecting procedure volumes. The company is optimistic about overcoming these temporary setbacks and achieving growth in 2025.Read More>---
BTMD Stock 12 Month Forecast
Average Price Target
$11.00
▲(151.72% Upside)
Technical Analysis
Best Analysts Covering BTMD
1 Year
1 Year Success Rate
2/9 ratings generated profit
1 Year Average Return
-6.31%
reiterated a buy rating last month
Copying George Kelly's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -6.31% per trade.
---